Quantcast
Home > Quotes > CWBR

CohBar, Inc. Common Stock (CWBR) Quote & Summary Data

CWBR 
$3.55
*  
0.15
4.05%
Get CWBR Alerts
*Delayed - data as of Dec. 13, 2018  -  Find a broker to begin trading CWBR now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
Today's High / Low
$ 3.73 / $ 3.55
Share Volume
18,794
50 Day Avg. Daily Volume
61,194
Previous Close
$ 3.70
52 Week High / Low
$ 10.789 / $ 2.55
Market Cap
151,075,635
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
1.76

Intraday Chart

Shares Traded

Share Volume:
18,794
50 Day Avg. Daily Volume:
61,194

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
Earnings Per Share (EPS):
$ -0.35

Trading Range

The current last sale of $3.55 is 39.22% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 3.73 $ 10.789
 Low: $ 3.55 $ 2.55

Company Description (as filed with the SEC)

CohBar, Inc. ("CohBar," "we," "us," "our," "its" or the "Company") is an innovative biotechnology company and a leader in the research and development of mitochondria based therapeutics (MBTs), an emerging class of drugs which may provide treatments for a wide range of diseases associated with aging and metabolic dysfunction, including non-alcoholic steatohepatitis (NASH), obesity, type 2 diabetes mellitus (T2D), cancer, atherosclerosis, cardiovascular disease and neurodegenerative diseases such as Alzheimer's disease. MBTs originate from almost two decades of research by our founders, resulting in their discovery of a novel group of mitochondrial-derived peptides (MDPs) encoded within the mitochondrial genome. Some of these naturally occurring MDPs and their analogs have demonstrated a range of biological activity and therapeutic potential in pre-clinical models across multiple diseases associated with aging.  ... More ...  

Nasdaq Official Price

Open Price:
$ 3.64
Open Date:
Dec. 13, 2018
Close Price:
$ 3.55
Close Date:
Dec. 13, 2018

Research Brokers before you trade

Want to trade FX?

Analyst Info